InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,634.61
(
1.15%
)
US TECH 100
19,202.80
(
1.10%
)
Dow Jones
41,175.08
(
1.14%
)
Brent Oil
78.38
(
0.00%
)
Bitcoin
64,011.90
(
-0.24%
)
Post# of 252969
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biocqr

Send PM Follow Ignore
Followers 49
Posts 3520
Boards Moderated 0
Alias Born 08/24/2005

biocqr

Member Level

Re: dewophile post# 235317

Wednesday, 10/28/2020 2:32:20 PM

Wednesday, October 28, 2020 2:32:20 PM

Post# of 252969
Eysuvis was trialed against placebo so no data vs. Lotemax and Lotemax wasn't trialed for DED flares. The SE profile is benign...AEs (2.9% vs 1.5% placebo) and IOP elevation (0/449) similar to placebo.

Lotemax is dosed .5% and Eysuvis .25%.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up